Long-term outcome of combined (percutaneous intramyocardial and intracoronary) application of autologous bone marrow mononuclear cells post myocardial infarction the 5-year MYSTAR study /
OBJECTIVE: The long-term (5-year) outcome of early (3-6 weeks after acute myocardial infarction [AMI], BM-MNC Early group) and late (3-4 months after AMI, BM-MNC Late group) combined (percutaneous intramyocardial and intracoronary) delivery of autologous bone marrow mononuclear cells (BM-MNCs) was...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
Public Library of Science (PLoS)
2016
|
| Sorozat: | PLOS ONE
11 No. 10 |
| doi: | 10.1371/journal.pone.0164908 |
| mtmt: | 3174445 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/11861 |